ALOGLIPTIN AND PIOGLITAZONE

ALOGLIPTIN AND PIOGLITAZONE was reported 249 times

These side effects are most commonly reported by patients taking ALOGLIPTIN AND PIOGLITAZONE:

# Side effect Count
0 WEIGHT INCREASED 21
1 DRUG INEFFECTIVE 11
2 FATIGUE 11
3 RASH 11
4 BLOOD GLUCOSE INCREASED 10
5 PANCREATITIS 10
6 HEADACHE 9
7 VISION BLURRED 9
8 ARTHRALGIA 8
9 MYALGIA 8
10 NAUSEA 8
11 ABDOMINAL PAIN UPPER 7
12 PAIN 7
13 JOINT SWELLING 6
14 OEDEMA 6
15 PERIPHERAL SWELLING 6
16 VOMITING 6
17 ACUTE KIDNEY INJURY 5
18 DIABETIC KETOACIDOSIS 5
19 DIARRHOEA 5
20 DIZZINESS 5
21 DYSGEUSIA 5
22 FLUID RETENTION 5
23 GLYCOSYLATED HAEMOGLOBIN INCREASED 5
24 HYPERTENSION 5
25 INSOMNIA 5
26 PRODUCT USE ISSUE 5
27 SWELLING 5
28 ALANINE AMINOTRANSFERASE INCREASED 4
29 ASPARTATE AMINOTRANSFERASE INCREASED 4
30 ASTHENIA 4
31 BLOOD GLUCOSE ABNORMAL 4
32 CARDIAC DISORDER 4
33 DRUG INTERACTION 4
34 HAEMATURIA 4
35 HOT FLUSH 4
36 LACTIC ACIDOSIS 4
37 MALAISE 4
38 OEDEMA PERIPHERAL 4
39 PAIN IN EXTREMITY 4
40 PANCREATITIS ACUTE 4
41 URTICARIA 4
42 ABDOMINAL DISTENSION 3
43 ANXIETY 3
44 BACK PAIN 3
45 BLOOD CREATININE INCREASED 3
46 CARDIAC FAILURE 3
47 CARDIAC FAILURE CONGESTIVE 3
48 CHEST PAIN 3
49 DEATH 3
50 DRUG LEVEL INCREASED 3
51 DRY MOUTH 3
52 DYSPNOEA 3
53 FACE OEDEMA 3
54 FALL 3
55 GENERALISED OEDEMA 3
56 HUNGER 3
57 LIVER FUNCTION TEST ABNORMAL 3
58 NO ADVERSE EVENT 3
59 PRURITUS 3
60 RENAL PAIN 3
61 SINUSITIS 3
62 THERAPEUTIC RESPONSE DECREASED 3
63 WEIGHT DECREASED 3
64 WHITE BLOOD CELL COUNT DECREASED 3
65 ABDOMINAL PAIN 2
66 ALOPECIA 2
67 ALTERED STATE OF CONSCIOUSNESS 2
68 ANAL ABSCESS 2
69 BLADDER TRANSITIONAL CELL CARCINOMA STAGE II 2
70 BLOOD GLUCOSE FLUCTUATION 2
71 BLOOD PH DECREASED 2
72 BLOOD UREA INCREASED 2
73 BURSITIS 2
74 DEHYDRATION 2
75 DRUG DOSE OMISSION 2
76 DYSPEPSIA 2
77 EMOTIONAL DISTRESS 2
78 ERYTHEMA NODOSUM 2
79 FEELING ABNORMAL 2
80 GAIT DISTURBANCE 2
81 GASTROINTESTINAL DISORDER 2
82 GENITAL ABSCESS 2
83 GLOMERULAR FILTRATION RATE DECREASED 2
84 HEPATIC PAIN 2
85 HYPOTENSION 2
86 INTENTIONAL PRODUCT USE ISSUE 2
87 IRRITABILITY 2
88 JAUNDICE 2
89 LABORATORY TEST ABNORMAL 2
90 LIP SWELLING 2
91 MACULAR OEDEMA 2
92 METASTASES TO LUNG 2
93 MIGRAINE 2
94 MUSCULAR WEAKNESS 2
95 NERVOUSNESS 2
96 PERICARDITIS 2
97 PNEUMONIA 2
98 RHEUMATOID ARTHRITIS 2
99 RHINORRHOEA 2
100 THERAPY CESSATION 2
101 UNEVALUABLE EVENT 2
102 URINE ODOUR ABNORMAL 2
103 ABDOMINAL DISCOMFORT 1
104 ABDOMINAL WALL HAEMATOMA 1
105 ADVERSE DRUG REACTION 1
106 ADVERSE EVENT 1
107 AMNESIA 1
108 ANAEMIA 1
109 ANGINA UNSTABLE 1
110 ANHEDONIA 1
111 ARTHROPOD BITE 1
112 ASTHMA 1
113 ATRIAL FIBRILLATION 1
114 ATRIAL FLUTTER 1
115 ATRIOVENTRICULAR BLOCK 1
116 BALANCE DISORDER 1
117 BLADDER TRANSITIONAL CELL CARCINOMA STAGE III 1
118 BLISTER 1
119 BLOOD BILIRUBIN INCREASED 1
120 BLOOD GLUCOSE DECREASED 1
121 BLOOD LOSS ANAEMIA 1
122 BLOOD THYROID STIMULATING HORMONE INCREASED 1
123 BODY HEIGHT DECREASED 1
124 BONE DENSITY DECREASED 1
125 BREAST PAIN 1
126 BRONCHITIS 1
127 CANDIDA INFECTION 1
128 CEREBROVASCULAR ACCIDENT 1
129 CHRONIC KIDNEY DISEASE 1
130 CIRCULATORY COLLAPSE 1
131 COLITIS 1
132 CONDITION AGGRAVATED 1
133 CONFUSIONAL STATE 1
134 CONTRAINDICATION TO MEDICAL TREATMENT 1
135 COUGH 1
136 DECREASED APPETITE 1
137 DEPRESSION 1
138 DERMATITIS 1
139 DEVICE ISSUE 1
140 DIABETES MELLITUS 1
141 DIABETES MELLITUS INADEQUATE CONTROL 1
142 DIPLOPIA 1
143 DISCOMFORT 1
144 DISTURBANCE IN ATTENTION 1
145 DIVERTICULITIS 1
146 DRUG ABUSE 1
147 DRUG ADMINISTRATION ERROR 1
148 DRUG EFFECT INCOMPLETE 1
149 DRUG HYPERSENSITIVITY 1
150 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1
151 DYSKINESIA 1
152 DYSPNOEA EXERTIONAL 1
153 DYSSTASIA 1
154 DYSURIA 1
155 EPIGASTRIC DISCOMFORT 1
156 EPISTAXIS 1
157 ERUCTATION 1
158 ERYTHEMA 1
159 EUGLYCAEMIC DIABETIC KETOACIDOSIS 1
160 FOURNIER^S GANGRENE 1
161 GALLBLADDER DISORDER 1
162 GANGRENE 1
163 GASTRIC DISORDER 1
164 GASTRIC ULCER 1
165 GASTROENTERITIS 1
166 GASTROINTESTINAL HAEMORRHAGE 1
167 GASTROINTESTINAL POLYP HAEMORRHAGE 1
168 GENITAL INFECTION FUNGAL 1
169 GLYCOSYLATED HAEMOGLOBIN DECREASED 1
170 HAEMATEMESIS 1
171 HAEMOGLOBIN DECREASED 1
172 HAIR TEXTURE ABNORMAL 1
173 HEAD DISCOMFORT 1
174 HEPATIC FAILURE 1
175 HICCUPS 1
176 HYPERSENSITIVITY 1
177 HYPOACUSIS 1
178 ILLNESS 1
179 IMMUNE SYSTEM DISORDER 1
180 INCREASED APPETITE 1
181 INFLUENZA LIKE ILLNESS 1
182 INFUSION RELATED REACTION 1
183 INJECTION SITE BRUISING 1
184 INJECTION SITE PAIN 1
185 INJURY 1
186 JOINT STIFFNESS 1
187 LIMB DISCOMFORT 1
188 LIPASE INCREASED 1
189 LIVER INJURY 1
190 LOWER LIMB FRACTURE 1
191 LUNG NEOPLASM MALIGNANT 1
192 MEMORY IMPAIRMENT 1
193 METABOLIC ENCEPHALOPATHY 1
194 MIDDLE INSOMNIA 1
195 MUSCLE STRAIN 1
196 MUSCULOSKELETAL CHEST PAIN 1
197 MYOCARDIAL INFARCTION 1
198 NASAL CONGESTION 1
199 NECROSIS 1
200 NECROTISING FASCIITIS 1
201 NEOPLASM MALIGNANT 1
202 NEPHROPATHY 1
203 OFF LABEL USE 1
204 OROPHARYNGEAL PAIN 1
205 OSTEOMYELITIS 1
206 OXYGEN SATURATION DECREASED 1
207 PANCYTOPENIA 1
208 PARAESTHESIA 1
209 PENILE OEDEMA 1
210 PENIS DISORDER 1
211 PERIRECTAL ABSCESS 1
212 POLLAKIURIA 1
213 POOR QUALITY SLEEP 1
214 POOR VENOUS ACCESS 1
215 PRODUCT PHYSICAL ISSUE 1
216 PRODUCT QUALITY ISSUE 1
217 PROTEIN URINE PRESENT 1
218 PRURITUS GENERALISED 1
219 PSORIASIS 1
220 PSYCHOTIC DISORDER 1
221 RECTAL HAEMORRHAGE 1
222 RENAL FAILURE 1
223 RESPIRATORY FAILURE 1
224 SEIZURE 1
225 SKIN EXFOLIATION 1
226 SKIN FIBROSIS 1
227 SKIN IRRITATION 1
228 SKIN ULCER 1
229 SOMNOLENCE 1
230 SPONDYLOLISTHESIS 1
231 STRESS 1
232 SWELLING FACE 1
233 TENDON RUPTURE 1
234 THINKING ABNORMAL 1
235 THROAT IRRITATION 1
236 TINNITUS 1
237 TOE AMPUTATION 1
238 TOOTH ABSCESS 1
239 URINARY TRACT INFECTION 1
240 VISUAL ACUITY REDUCED 1
241 VULVOVAGINAL BURNING SENSATION 1
242 VULVOVAGINAL PRURITUS 1
243 WEIGHT FLUCTUATION 1
244 WOUND INFECTION STAPHYLOCOCCAL 1
245 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1